Clinical Trial Update: Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers

View source ↗

Summary

A completed clinical trial studying the burden of disease in patients with transthyretin familial amyloidosis polyneuropathy (TTR-FAP) or transthyretin cardiomy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Amyloid Cardiomyopathy
• Senile Systemic Amyloidosis
• Transthyretin Cardiomyopathy
• Transthyretin Familial Amyloidosis Polyneuropathy

Snippet

Sponsor: Pfizer | Conditions: Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP), Transthyretin Cardiomyopathy (TTR-CM) | Status: COMPLETED | Results posted: 2017-04-12